Registry to Study Gene Testing for Diagnosis and Treatment of Genetic Arrhythmic Heart Disease Collecting Clinical and Genetic Data at the University of Ferrara Cardiogenetic Center

What this Trial Is About

This observational study focuses on patients evaluated at the specialized Cardiogenetic Center within the Cardiology Department of the University of Ferrara, Italy. It aims to collect detailed clinical, genetic, and electrophysiological information from individuals with suspected or confirmed genetic arrhythmogenic heart conditions. The goal is to improve understanding of the genetic causes and clinical impact of inherited arrhythmias and systemic syndromes, supporting better diagnosis and personalized care. No experimental treatments are involved as this is a registry study. Data collected includes patient demographics, family history, clinical symptoms, diagnostic results, and treatment outcomes. The registry supports long-term follow-up to observe the natural progression of arrhythmogenic disorders and to evaluate the effectiveness of various therapies over time. Participants will be monitored through regular data collection on health outcomes such as death rates, heart failure, and arrhythmia events at one and five years. The study also tracks the need for devices like pacemakers or defibrillators and genetic mutation types. This long-term observational approach helps identify risk factors for adverse events and informs future research and clinical guidelines, with participation lasting several years until the study end date in 2035.

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART